New research by PerkinElmer confirms that PD-L1 protein expression levels in human breast cancer cells can be quickly and accurately assessed directly with the AlphaLISA human PD-L1 assay.
To help global regulators identify, quantify, and qualify microplastics in the waterways around the globe researchers are deploying PerkinElmer's infrared (IR) spectroscopy instruments.
Using the Attivo and SciBite TERMite platforms, researchers can now unlock the value of unstructured data found in electronic medical records, to reveal medical discoveries that would otherwise be lost in too much data.
With the use of potentially harmful pesticides to protect berry crops on the rise, PerkinElmer introduces unique ways to detect and quantify pesticide residue in fruit.
Scientists at UCLA's David Geffen School of Medicine are working with bioluminescent, fluorescent, and positron emission tomography (PET) technologies to reduce infections in post-surgical orthopedic patients as well as fight against metabolic cancer.
Amid increased complexity of regulations, PerkinElmer's QSight™ Pesticide Analyzer solution provides labs with more uptime and competitive advantage to meet regulatory requirements.
A review of the growing dangers associated with antibiotics in milk and PerkinElmer's latest technology to discover these drugs in milk samples.
Missouri University Science and Technology researchers develop new SP-ICP-MS methodology to test for the presence of nanomaterials in drinking water.
Researchers offer evidence of the importance of epithelial-to-mesenchymal transition (EMT) in the progression of chronic kidney disease.
PerkinElmer recently introduced the Avio™ 200 instrument as the world's smallest inductively coupled plasma optical emission spectrometer (ICP-OES).